Lifitegrast API | Manufacturer & Supplier in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Lifitegrast API Manufacturer in India

Lifitegrast is a small-molecule lymphocyte function-associated antigen-1 (LFA-1) antagonist used in ophthalmic pharmaceutical formulations for the treatment of signs and symptoms of dry eye disease. It is a tetrahydroisoquinoline derivative that targets the LFA-1/ICAM-1 inflammatory pathway.

Lifitegrast has the CAS Number 1025967-78-5, molecular formula C29H24Cl2N2O7S and molecular weight 615.48 g/mol. It is supplied as a white to off-white solid or powder and is practically insoluble in water.

Lifitegrast API Overview

Lifitegrast is a selective antagonist of lymphocyte function-associated antigen-1 (LFA-1), an integrin expressed on leukocytes. By binding to LFA-1, lifitegrast blocks its interaction with intercellular adhesion molecule-1 (ICAM-1), a pathway involved in T-cell-mediated inflammation.

Lifitegrast is used as an active pharmaceutical ingredient in ophthalmic drug development and is associated with the treatment of dry eye disease. The API has a defined stereochemical configuration and is characterized by its chemical purity, identity and physical properties.

Lifitegrast Applications

  • Ophthalmic pharmaceutical formulation development
  • Dry eye disease pharmaceutical development
  • LFA-1 and ICAM-1 pathway research
  • Inflammation and immunology research
  • Pharmaceutical research and development
  • Analytical and quality-control research

Mechanism of Action of Lifitegrast

Lifitegrast binds to lymphocyte function-associated antigen-1 (LFA-1) on leukocytes and inhibits its interaction with intercellular adhesion molecule-1 (ICAM-1). This can interfere with T-cell adhesion, activation and migration and reduce inflammatory signaling associated with dry eye disease.

Lifitegrast API Manufacturer and Supplier

Swapproop Drugs and Pharmaceuticals supports the sourcing and supply of Lifitegrast API for qualified pharmaceutical and research requirements. The product can be evaluated according to applicable customer specifications and validated quality-control requirements.

For Lifitegrast API availability, technical documentation, specifications and commercial requirements, contact Swapproop Drugs and Pharmaceuticals.

Why Choose Lifitegrast API?

  • Well-characterized ophthalmic API
  • Defined LFA-1 antagonist activity
  • Suitable for pharmaceutical formulation development
  • High-purity API options available
  • Suitable for analytical and pharmaceutical research
  • Technical documentation support

Lifitegrast Technical Information

  • CAS Number: 1025967-78-5
  • Molecular Formula: C29H24Cl2N2O7S
  • Molecular Weight: 615.48 g/mol
  • FDA UNII: 038E5L962W
  • PubChem Compound ID: 11965427

Detailed Specifications

Parameter Specification
Appearance White to off-white crystalline powder
Identification IR & HPLC compliant
Assay (HPLC) NLT 99.0% on dried substance basis
Loss on Drying NMT 1.0%
Residue on Ignition NMT 0.5%
Individual Impurity ≤ 0.5%
Total Impurities ≤ 1.5%
Water Content NMT 1.0%
Get Bulk Quote via WhatsApp